There was a general decrease in expression across all AD cases compared to untreated cells, most profoundly for those treated with AD1, AD2, AD4, and AD6 tau, but not AD3 and AD5, suggesting that these genes are altered with pathological tau seeding and accumulation. Here, MAPT is linked to Alzheimer disease.